Given that IC2 has been reported to inhibit SCD1 activity, we speculated that interference with the lipid synthesis process in cancer cells may cause an imbalance between saturated and unsaturated FAs, potentially leading to lipotoxicity. This evidence concerns the gene SCD and cancer.